#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pouchitis Non-small cell lung cancer recurrent Acute lymphocytic leukaemia Squamous cell carcinoma of the cervix Oesophageal squamous cell carcinoma stage III Chorioretinitis Peritoneal mesothelioma malignant Eosinophilic oesophagitis Angiosarcoma non-metastatic Vascular calcification Amyotrophic lateral sclerosis gene carrier X-linked lymphoproliferative syndrome Acromegaly Neurofibromatosis Immune-mediated renal disorder More trials…

    Learn about Rare Diseases

    Activated PI3 kinase delta syndrome Familial amyotrophic lateral sclerosis – Basic Information Haemophilia B without inhibitors Lysosomal storage disorder – Trials in Disease Haemophilia IgA nephropathy – Basic Information Toxic epidermal necrolysis Systemic sclerosis pulmonary – Trials in Disease Cystic fibrosis – Diagnostics Lymphangiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Chlortalidone Metronidazole Crgd-Zw800-1 Cetrelimab L-METHIONINE Tertomotide Valaciclovir Ribonucleic Acid Mosunetuzumab Islatravir 19Cp02 [18F]Fapi-74 Belzutifan Magnesium Donepezil Hydrochloride Canis Familiaris (553) Hypromellose Mk-6194 Dexamethasone Base Teropavimab More therapies…

    Learn about Your Condition

    Herpes simplex Obsessive-compulsive disorder Lysosomal storage disorder Mitral valve incompetence Prodromal Alzheimer's disease Langerhans cell sarcoma Combined immunodeficiency Prostate cancer Apheresis Infectious pleural effusion Kidney transplant rejection Synovitis Kawasaki's disease Splenic marginal zone lymphoma Nocturia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • A study comparing injection under the skin versus infusion into the vein of tislelizumab with chemotherapy for patients with advanced gastric or gastroesophageal junction cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Tislelizumab
    Austria Czechia France Italy Poland Spain

  • A study testing ASP5541 compared to abiraterone acetate in patients with advanced prostate cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • ABIRATERONE DECANOATE
    • Abiraterone Acetate
    • Prednisolone
    France Germany Italy Poland Spain

  • Study of BNT326 alone and with BNT327 in patients with advanced solid tumors: Testing safety and effectiveness of new cancer treatments

    Recruiting

    1 1 1
    Investigated Drugs:
    • BNT327
    Belgium Germany Italy Spain

  • Study of MT-501 in patients with active Crohn’s Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial

    Recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    • Colitis ulcerative
    Belgium Bulgaria Croatia Czechia Germany Italy +2

  • Study of depemokimab to improve airway function in patients with type 2 eosinophilic asthma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Depemokimab
    Belgium France Germany Greece Italy Spain

  • Study of XELOX chemotherapy with or without dostarlimab after chemoradiation in patients with locally advanced rectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Dostarlimab
    Italy

  • Study of toripalimab, cisplatin and gemcitabine combination as first treatment for patients with recurrent or metastatic nasopharyngeal cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Nasopharyngeal cancer
    Investigated Drugs:
    • Toripalimab
    • Cisplatin
    • Gemcitabine
    Italy

  • Study of pembrolizumab and lenvatinib treatment for patients with vulvar cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    Italy

  • Study of Mosunetuzumab Treatment in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Mosunetuzumab
    Italy

  • Study of momelotinib tablets in patients with anemia caused by low-risk myelodysplastic syndrome

    Recruiting

    2 1 1
    Investigated Drugs:
    • Momelotinib Dihydrochloride Monohydrate
    France Germany Italy Poland Spain
Previous Page
1 … 9 10 11 12 13 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!